Point72 Hong Kong LTD Exact Sciences Corp Transaction History

Point72 Hong Kong LTD

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $275,300 - $589,334	-7,731 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $444,996 - $638,116	7,731 New	7,731 $541,000
Q3 2021 Nov 15, 2021	SELL	$90.24 - $124.05 $902,490 - $1.24 Million	-10,001 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $936,693 - $1.39 Million	10,001 New	10,001 $1.24 Million
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $658,503 - $875,651	-5,649 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $481,415 - $686,865	-4,833 Reduced 46.11%	5,649 $748,000
Q3 2020 Nov 16, 2020	BUY	$72.92 - $102.01 $581,974 - $814,141	7,981 Added 319.11%	10,482 $1.07 Million
Q2 2020 Aug 14, 2020	BUY	$55.75 - $92.75 $139,430 - $231,967	2,501 New	2,501 $217,000
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $5,436 - $6,981	-70 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $1,265 - $1,714	14 Added 25.0%	70 $6,000
Q2 2019 Aug 14, 2019	BUY	$89.51 - $118.04 $5,012 - $6,610	56 New	56 $7,000
Q3 2018 Nov 14, 2018	SELL	$48.29 - $80.6 $18,881 - $31,514	-391 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$37.84 - $69.96 $14,795 - $27,354	391 New	391 $23,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.